ArticleACS medicinal chemistry letters2020

Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist.

Robert J Cherney et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.